2 completed, 1 unknown, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Leukemia, Chronic Lymphatic: new trials by email Literature Review of Leukemia, Chronic Lymphatic trials Research Report on Leukemia, Chronic Lymphatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atrial Fibrillation in Patients Receiving Ibrutinib Leukemia, Chronic Lymphatic, Mantle Cell Lymphoma | Unknown | European Georges Pompidou Hospital | 60 | 2020-05-21 | 2020-06-09 | |
| Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Ibrutinib, Fludarabine, Pembrolizumab - B-Cell Chronic Lymphocytic Leukemia, B-Lymphocytic Leukemia, Chronic | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 15 | 2017-09-22 | 2026-01-30 |
| iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL Peptide Vaccine, Imiquimod - Leukemia, Chronic Lymphatic | Phase 2 | Completed | University Hospital Tuebingen | 56 | 2016-10-05 | 2022-11-28 |
| Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia splenic irradiation - Leukemia, Chronic Lymphatic | Withdrawn | Maastricht Radiation Oncology | 2013-09-01 | 2018-04-05 |
Leukemia, Lymphocytic, Chronic, B-Cell (4) · Atrial Fibrillation (1) · Chromosome 17 deletion (1) · Hypertension (1) · Lymphoma, Mantle-Cell (1)
Chronic Disease (4) · Disease Attributes (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Leukemia (4) · Leukemia, B-Cell (4) · Leukemia, Lymphoid (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4)
Imiquimod (1) · Protein Subunit Vaccines (1) · fludarabine (1) · fludarabine phosphate (1) · ibrutinib (1) · pembrolizumab (1)
European Georges Pompidou Hospital (1) · Maastricht Radiation Oncology (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · University Hospital Tuebingen (1)
France (1) · Germany (1) · Netherlands (1) · United States (1)
Adrian U Wiestner, M.D. (1) · Jacques Borger, dr. (1)